SynergEyes Inc. has recently launched a revolutionary hybrid contact lens designed for people who need further vision correction after undergoing refractive vision surgery, such as LASIK. SynergEyes(R) PS (post-surgical) is also designed for patients who have experienced some type of corneal trauma or suffer from certain degenerative vision conditions. Approved for marketing by the FDA, SynergEyes PS hybrid contact lenses bond a “hard” and “soft” contact lens together resulting in a one-of-a-kind vision correction option that provides crisp, clear vision for surgically altered corneas in a comfortable, healthy contact lens.

STAAR Surgical Company has received approval from the Sate Food and Drug Administration (SFDA) of the People’s Republic of China to market its Visian™ Toric Implantable Collamer Lens (ICL) in the country for treating nearsightedness and astigmatism. This lens, made of a highly biocompatible material called Collamer, is minimally invasive and foldable. The ICL procedure makes an incision that is as much as 50% smaller than that made by other technologies and the lens is placed behind the iris.